Journal of Capital Medical University ›› 2016, Vol. 37 ›› Issue (6): 763-766.doi: 10.3969/j.issn.1006-7795.2016.06.009

Previous Articles     Next Articles

Clinical study for resection range for early stage non-small cell lung cancer patients

Hu Mu, Zhang Yi, Xu Qingsheng, Liu Baodong, Su Lei, Wang Ruotian, Zhi Xiuyi   

  1. Department of Thoracic Surgery, Xuanwu Hospital, Capital Medical University, Beijing 100053, China
  • Received:2016-10-03 Online:2016-12-21 Published:2016-12-16
  • Supported by:
    This study was supported by Beijing Municipal Science and Technology Commission Major Projects (D14110700020000).

Abstract: Objective To compare video assisted thoracic surgery(VATS) lobectomy and sublobectomy in the treatment of early stage non-small cell lung cancer on safety and short term follow up. Methods The early lung cancer patients with lesion 2 cm or less in diameter were divided into lobectomy and sublobectomy resection group. Two groups were compared in the hospitalization after operation, operation time, surgical blood loss, postoperative complications and postoperative recurrence at 1-year, mortality and postoperative lung function reduction rate after 1 year. Results Comparing two groups, sublobecomy group had a shorter operation time than lobectomy group (P=0.000). Surgical blood loss, postoperative hospital stay and postoperative complications had no significant difference (P>0.05) between two groups. After 1 year follow-up, no mortality was found in any group, no tumor recurrence or metastasis was found in any group. In sublobectomy group, reduction of lung function 1 year after surgery was obviously better than the ratio of lobectomy group (P=0.000). Conclusion Safety and effectiveness of VATS sublobectomy for early stage non-small cell lung cancer patients compared with lobectomy have been established in this study.

Key words: non-small cell lung cancer, sublobectomy resection, lobectomy, early stage

CLC Number: